Recent Quotes
My Watchlist
Indicators
Local Stocks
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adaptimmune Ther Ads (NQ: ADAP )

5.020 USD +0.140 (+2.87%)
Streaming Delayed Price Updated: 11:24 AM EDT, Apr 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Adaptimmune Ther Ads

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
CORRECTING and REPLACING -- Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
In a release issued under the same headline earlier today by Adaptimmune Therapeutics plc (Nasdaq:ADAP), please note that the third subheadline should read, "Treating patients in expansion phases of... 
From GlobeNewswire News Releases
Adaptimmune Reports Fourth Quarter / Full Year 2018 Financial Results and Business Update
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today reported financial results for the fourth quarter and year ended December 31, 2018 and provided a business... 
From GlobeNewswire News Releases
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs
Biotech stocks came under pressure in the week ending Feb. 22 after advancing in the previous week. The recent week was fairly quiet for ... 
Tags AIMT BMY Trading Ideas
From Benzinga
58 Biggest Movers From Yesterday
Gainers Diebold Nixdorf, Incorporated (NYSE: DBD) shares climbed 39.08 percent to close at $7.26 after reporting upbeat Q4 ... 
Tags Market News CERC Materials
From Benzinga
26 Stocks Moving In Tuesday's Pre-Market Session
Gainers SCWorx Corp. (NASDAQ: WORX) rose 44.4 percent to $7.15 in pre-market trading after climbing 19.19 percent on ... 
Tags #PreMarket Gainers Movers BRS
From Benzinga
Adaptimmune to Report Fourth Quarter / Full Year 2018 Financial Results and Business Update on Wednesday, February 27, 2019
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Fourth Quarter / Full Year 2018 and provide a general business update... 
From GlobeNewswire News Releases
With the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program (ADAP), Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product
From ACCESSWIRE
First Week of ADAP February 15th Options Trading
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down... 
Tags Stocks
From Market News Video
Dose Escalation in Liver Cancer Study with ADP-A2AFP (AFP) SPEAR T-cells and Moving to Expansion Phase in ADP-A2M10 (MAGE-A10) Lung Cancer Study after Favorable Safety Reviews
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced that the Safety Review Committee (SRC) has endorsed dose escalation in the ongoing ADP-A2AFP... 
From GlobeNewswire News Releases
50 Biggest Movers From Monday
Gainers Lincoln Educational Services Corporation (NASDAQ: LINC) shares climbed 45.45 percent to close at $3.20 on Monday. China ... 
Tags SBPH VXRT KFS
From Benzinga
Analysts Forecast 27% Gains Ahead For The Holdings of ADRD
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
55 Biggest Movers From Monday
Gainers MINDBODY Inc (NASDAQ: MB) shares jumped 64.96 percent to close at $35.83 on Monday after the company agreed to be acquired ... 
Tags General DBVT Movers
From Benzinga
The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags BTAI DRRX DOVA
From Benzinga
50 Biggest Movers From Yesterday
Gainers Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) surged 51.38 percent to close at $0.1211 on Monday after Health Canada ... 
Tags CYH Integrated Telecommunication Services AEYE
From Benzinga
52 Biggest Movers From Yesterday
Gainers Sparton Corporation (NYSE: SPA) shares climbed 39.63 percent to close at $18.32 on Wednesday after the company agreed to ... 
Tags Trading Ideas NTRP ONCY
From Benzinga
41 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sparton Corporation (NYSE: SPA) surged 39.3 percent to $18.27 after the company agreed to be purchased by Cerberus at ... 
Tags OSS FOMX NX
From Benzinga
Adaptimmune Announces that Gwen Binder will leave in January 2019
Adaptimmune (Nasdaq: ADAP), a leader in T-cell therapy to treat cancer, today announced that Gwen Binder, PhD, Chief Technology Officer, will be leaving the company at the end of January 2019. 
From GlobeNewswire News Releases
48 Biggest Movers From Yesterday
Gainers Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) climbed 100 percent to close at $2.80 on Thursday after the company reported ... 
Tags BHTG BITA I
From Benzinga
Recent Analysis Shows Bellicum Pharmaceuticals, NetEase, Nice, Match Group, SpartanNash, and Adaptimmune Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Bellicum... 
From GlobeNewswire News Releases
The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs ... 
Tags XBI BTAI RVNC
From Benzinga
How The Pieces Add Up: ADRD Targets $25
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags ATNX PAVM SMMT
From Benzinga
The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags IBB PLXP SRDX
From Benzinga
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today reported financial results for the third quarter ended September 30, 2018, and provided a business update. 
From GlobeNewswire News Releases
The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting ... 
Tags STIM CMRX FLGT
From Benzinga
The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs
Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy ... 
Tags LGND MACK BOLD
From Benzinga
Adaptimmune to Report Third Quarter 2018 Financial Results and Business Update on Tuesday, November 6, 2018
Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will announce financial results for the Third Quarter 2018 and provide a general business update before the U.S.... 
From GlobeNewswire News Releases
3 Beaten-Down Biotech Stocks: Can They Bounce Back?
See if these oncology-driven drugmakers have what it takes to recover from recent setbacks. 
Tags ADRO MRK JNJ
From Motley Fool
The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price
Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs in ... 
Tags HALO TRIL CMRX
From Benzinga
January 2019 Options Now Available For Adaptimmune Therapeutics (ADAP)
Investors in Adaptimmune Therapeutics PLC (ADAP) saw new options begin trading today, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.